Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis. NLM AIDSLINE Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis.

Infect Control. 1985 Aug;6(8):301-5. Unique Identifier : AIDSLINE MED/85288030
Favero MS

Abstract: Precautions used for dialysis patients who have acquired immunodeficiency syndrome or non-A, non-B hepatitis are based on infection control strategies developed for the control of hepatitis B in dialysis centers. Specifically, these recommendations include identifying infected patients; isolating (except for non-A, non-B hepatitis patients) patients, and separating staff, and equipment; applying blood precautions and aseptic techniques; and using good environmental control procedures. AIDS patients can be safely dialyzed by either hemodialysis or peritoneal dialysis in hospital-based or free-standing centers, or at home without risk of AIDS transmission to other patients or to staff members, if precautions that have been developed for the control of hepatitis B infection in dialysis units are employed. Further, the type of dialysis treatment, or modality, should be based on the needs of the patient and not on a fear of risk of disease transmission.
Keywords: Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL/ TRANSMISSION Equipment Contamination/PREVENTION & CONTROL Hemodialysis/*STANDARDS Hepatitis B/PREVENTION & CONTROL/TRANSMISSION Hepatitis C/*PREVENTION & CONTROL/TRANSMISSION Hepatitis, Viral, Human/*PREVENTION & CONTROL Human Patient Isolation JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDprevention&control/transmissionequipmentcontamination/prevention&controlhemodialysis/KWDstandardshepatitisb/prevention&control/transmissionhepatitisc/KWDprevention&control/transmissionhepatitis,viral,human/KWDprevention&controlhumanpatientisolationjournalarticle
851230
M85C0131

Copyright © 1985 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .